Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cleveland Biolabs Inc (NASDAQ:CBLI)

3.00
Delayed Data
As of Dec 12
 +0.22 / +7.91%
Today’s Change
1.22
Today|||52-Week Range
5.55
+111.27%
Year-to-Date
No recent news for Cleveland Biolabs Inc.

Today’s Trading

Previous close2.78
Today’s open2.83
Day’s range2.76 - 3.09
Volume78,119
Average volume (3 months)53,592
Market cap$31.4M
Data as of 3:59pm ET, 12/12/2017

Growth & Valuation

Earnings growth (last year)+86.59%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+29.92%
P/E ratioNM
Price/Sales4.43
Price/Book4.06

Competitors

 Today’s
change
Today’s
% change
TPIVTapImmune Inc-0.02-0.64%
VKTXViking Therapeutics ...-0.08-2.02%
SLNOSoleno Therapeutics ...+0.06+3.41%
CATBCatabasis Pharmaceut...-0.04-2.30%
Data as of 4:00pm ET, 12/12/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$3.5M
Annual profit (last year)-$2.7M
Net profit margin-75.57%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Yakov Kogan
President &
Chief Medical Officer
Langdon L. Miller
Corporate headquarters
Buffalo, New York

Forecasts